David A Heath, a director at $CTRN, bought 1,000 shares of the company on 03-25-2026 for an estimated $44,500. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 12.8%. Following this trade, they now own 8,788 shares of this class of $CTRN stock.
$CTRN Insider Trading Activity
$CTRN insiders have traded $CTRN stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CTRN stock by insiders over the last 6 months:
- DAVID A HEATH purchased 1,000 shares for an estimated $44,500
- KATRINA GEORGE (VP of Human Resources) sold 450 shares for an estimated $20,349
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CTRN Hedge Fund Activity
We have seen 77 institutional investors add shares of $CTRN stock to their portfolio, and 61 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SHAY CAPITAL LLC removed 1,040,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $43,222,400
- LONG FOCUS CAPITAL MANAGEMENT, LLC removed 242,668 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $10,085,282
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 190,831 shares (+1554.5%) to their portfolio in Q4 2025, for an estimated $7,930,936
- GENERAL EQUITY HOLDINGS LP removed 172,229 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $5,344,265
- BROAD BAY CAPITAL MANAGEMENT, LP added 160,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $6,649,600
- DISCOVERY CAPITAL MANAGEMENT, LLC / CT removed 152,896 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,354,357
- AQR CAPITAL MANAGEMENT LLC added 128,508 shares (+239.6%) to their portfolio in Q4 2025, for an estimated $5,340,792
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CTRN Revenue
$CTRN had revenues of $230.4M in Q4 2025. This is an increase of 9.1% from the same period in the prior year.
You can track CTRN financials on Quiver Quantitative's CTRN stock page.
$CTRN Analyst Ratings
Wall Street analysts have issued reports on $CTRN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- DA Davidson issued a "Buy" rating on 12/03/2025
To track analyst ratings and price targets for $CTRN, check out Quiver Quantitative's $CTRN forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
